glp 1 agonist anti inflammatory GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Beyond Weight Loss: How GLP-1

GLP-1s blueprint was finally decoded: it was not an independent molecule, but a fragment snipped from a larger protein called proglucagon

A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity

doi: 10.3389/fendo.2018.00233 71 EverardABelzerCGeurtsLOuwerkerkJPDruartCBindelsLBet al

For self-funded employers, this reinforces a critical point: this isnt a one-time strategy decisionits a moving target

Nausea and appetite changes Nausea is the single most reported side effect across all GLP-1 agonist peptides, and retatrutide is no exception

Understanding the primary FDA-approved purpose of each medication is the easiest way to narrow down your options